91271-59-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
[3-(PYRROLIDIN-1-YLMETHYL)PHENYL]METHANOL serves as a valuable component in pharmaceutical research and drug development due to its potential therapeutic applications. It is recognized for its possible sedative, analgesic, and anticonvulsant properties, making it a candidate for treating various medical conditions such as epilepsy and chronic pain.
Used in Organic Chemical Production:
[3-(PYRROLIDIN-1-YLMETHYL)PHENYL]METHANOL may also find applications in the production of organic chemicals, contributing to the synthesis of various chemical products that have a wide range of uses across different industries.
Used in Agrochemicals Production:
Furthermore, [3-(PYRROLIDIN-1-YLMETHYL)PHENYL]METHANOL may be utilized in the development and manufacturing of agrochemicals, which are essential for enhancing crop protection and agricultural productivity.
Check Digit Verification of cas no
The CAS Registry Mumber 91271-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,2,7 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91271-59:
(7*9)+(6*1)+(5*2)+(4*7)+(3*1)+(2*5)+(1*9)=129
129 % 10 = 9
So 91271-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO/c14-10-12-5-3-4-11(8-12)9-13-6-1-2-7-13/h3-5,8,14H,1-2,6-7,9-10H2
91271-59-9Relevant articles and documents
TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE
-
Paragraph 00585, (2017/03/28)
The present invention provides compounds of Formula (I): wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRMIDINE INHIBITORS OF MYELOPEROXIDASE
-
Paragraph 00196, (2016/04/20)
The present invention provides compounds of Formula (I):wherein A, X and Y are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.